Wells Fargo Maintains Equal-Weight on HCA Healthcare, Lowers Price Target to $267
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an Equal-Weight rating on HCA Healthcare (NYSE:HCA) but lowered the price target from $275 to $267.
October 20, 2023 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on HCA Healthcare but lowered the price target from $275 to $267.
The lowering of the price target by Wells Fargo could potentially lead to a negative sentiment among investors, which may put downward pressure on HCA Healthcare's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100